Nebuflow has been awarded a £2m Scottish Enterprise grant to accelerate development and patient access to its patented nebuliser technology in the UK and globally. The technology is designed to improve how people receive inhaled medicines, paving the way for the medicines of tomorrow and reducing pressure on healthcare systems.
For full details please click here.